BSEGenpharmasec LtdLowNeutral
Announced Mon, 29 Sept · 14:56 IST

Submission of proceeding of the 33rd Annual General Meeting of the Members of the Genpharmasec Limited held on Monday, 29th September, 2025.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Genpharmasec Limited held its 33rd AGM on Monday, September 29, 2025, via video conferencing from 11:04 AM to 11:20 AM, with 56 members in attendance. The meeting, chaired by Mr. Sohan Chaturvedi (Whole Time Director & CFO), put 7 resolutions to vote. Ordinary business included adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, re-appointment of Mr. Rajesh Sadhwani (DIN: 08315182) as director (retiring by rotation), and appointment of M/s. Bilimoria Mehta & Co. as statutory auditors. Special business included a revision in remuneration for Mr. Sohan Chaturvedi, appointment of M/s. Jaymin Modi & Co. as secretarial auditor, and approval of material related party transactions.

Likely market impact

Routine AGM proceedings — voting results are pending and will be filed separately. For shareholders, the key items to watch are the revision in the CFO/Whole-Time Director's remuneration and the approval of material related party transactions, both of which could affect minority shareholder interests.